AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER 2010
(Rs. In Lacs except per share data) |
| PARTICULARS |
Quarter Ended |
Quarter Ended |
Nine Months Ended |
Nine Months Ended |
Year ended |
| 31st Dec 2010 |
31st Dec 2009 |
31st Dec 2010 |
31st Dec 2009 |
31st Mar 2010 |
| Gross Sales / Income from operations |
14,181 |
12,250 |
37,589 |
36,474 |
49,695 |
| Less : Excise Duty & Sales Tax |
577 |
547 |
1,892 |
1,817 |
2,553 |
| 1. |
(a) |
Net Sales / Income from operations |
13,604 |
11,703 |
35,697 |
34,657 |
47,142 |
|
(b) |
Other Operating Income |
|
|
|
|
|
| 2. |
Expenditure |
|
|
|
|
|
|
(a). |
(Increase) / Decrease in stock in trade |
(707) |
81 |
(1,971) |
(23) |
376 |
|
(b). |
Consumption of raw materials. |
7,600 |
5,811 |
19,705 |
17,454 |
23,179 |
|
(c). |
Purchase of Traded Goods |
2,621 |
2,190 |
6,572 |
5,944 |
8,202 |
|
(d). |
Employees cost |
409 |
345 |
1,214 |
1,012 |
1,362 |
|
(e). |
Depreciation |
393 |
341 |
1,131 |
1,004 |
1,352 |
|
(f). |
Other expenditure |
2,155 |
1,797 |
5,701 |
4,957 |
6,859 |
|
(g). |
Total Expenditure |
12,471 |
10,565 |
32,352 |
30,347 |
41,330 |
| 3. |
Profit from Operating before Other Income |
1,133 |
1,139 |
3,345 |
4,310 |
5,811 |
| 4. |
Other Income |
2 |
3 |
7 |
34 |
45 |
| 5. |
Profit before Interest & Exceptional Items |
1,135 |
1,142 |
3,352 |
4,344 |
5,856 |
| 6. |
Interest |
377 |
311 |
939 |
1,143 |
1,474 |
| 7. |
Profit after Interest but before Exceptional Items |
758 |
831 |
2,413 |
3,201 |
4,382 |
| 8. |
Exceptional Items |
- |
- |
- |
- |
- |
| 9. |
Profit from Ordinary Activities before Tax |
758 |
831 |
2,413 |
3,201 |
4,382 |
| 10. |
Tax Expenses (Includes) |
256 |
351 |
795 |
1,314 |
1,772 |
|
(a). |
Provision for Taxation |
184 |
284 |
586 |
1,111 |
1,502 |
|
(b). |
Provision for Deffered Taxation |
72 |
67 |
209 |
203 |
270 |
| 11. |
Net profit from ordinary Activities after Tax |
502 |
480 |
1,618 |
1,887 |
2,610 |
| 12. |
Extraodinary Item (net of tax expenses ) |
- |
- |
- |
- |
- |
| 13. |
Net Profit for the period |
502 |
480 |
1,618 |
1,887 |
2,610 |
| 14. |
Paid-up Equity Share Capital of Rs.10/- each. |
1,211 |
1,211 |
1,211 |
1,211 |
1,211 |
| 15. |
Reserves & Surplus (excluding revaluation reserves) |
- |
- |
- |
- |
12,898 |
| 16. |
Basic & Diluted E P S (in Rs.) |
4.15 |
3.96 |
13.36 |
15.58 |
22.08 |
| 17. |
Public Shareholding |
|
|
|
|
|
|
-Number of Shares |
5638133 |
6051226 |
5638133 |
6051226 |
6051226 |
|
-Percentage of Total Shareholding |
46.56 |
49.97 |
46.56 |
49.97 |
49.97 |
| 18. |
Promoters & Promoter Group |
|
|
|
|
|
|
Shareholding |
|
|
|
|
|
|
(a) |
Pledged/Encumbered |
|
|
|
|
|
|
- Number of Shares |
NIL |
NIL |
NIL |
NIL |
NIL |
|
-Percentage of shares( as a percentage of the |
NIL |
NIL |
NIL |
NIL |
NIL |
|
total shareholding of promoter and promoter group) |
|
|
|
|
|
|
-Percentage of shares( as a percentage of |
NIL |
NIL |
NIL |
NIL |
NIL |
|
total sharecapital of the Company) |
|
|
|
|
|
|
b) |
Non-encumbered |
|
|
|
|
|
|
- Number of Shares |
6470417 |
6057324 |
6470417 |
6057324 |
6057324 |
|
-Percentage of shares( as a percentage of |
100 |
100 |
100 |
100 |
100 |
|
total shareholding of promoter and promoter group) |
|
|
|
|
|
|
-Percentage of shares( as a percentage of |
53.44 |
50.03 |
53.44 |
50.03 |
50.03 |
|
total sharecapital of the Company) |
|
|
|
|
|
|
Notes :
1. The above results for the quarter and nine months ended 31st December,2010 have been reviewed by the Audit
Committee and approved by the Board of Directors in their Meeting held on 2nd February,2011.
2. Company is operating as a Single Segment Company, engaged in pharmaceuticals business hence, the disclosure requirement
as per AS - 17 'Segment Reporting' is not attracted.
3. The Board of Directors have declared Interim Dividend of Rs.2.50 paise per equity share of Rs.10/- each
( 25%) amounting to Rs.3,02,71,375 and 8th February,2011 has been fixed as record date for the payment of the said
interim dividend.
4. Details of Investors Complaints received for the quarter ended 31st December,2010
Beginning:- 1 Received:-4 Resolved:-3 Pending:- 2
5. Figures for the previous period have been regrouped or rearranged wherever necessary.
|
|
For and on behalf of the Board
|
|
FOR AARTI DRUGS LIMITED
|
|
| Place : Mumbai |
|
Harshit M Savla
|
| DATE : 2nd February, 2011 |
(Jt. Managing Director)
|
|
